Polyalkylcyanoacrylate agents and methods for enhancing contrast

Details Polyalkylcyanoacrylate agents and methods for enhancing contrast Polyalkylcyanoacrylate agents and methods for enhancing contrast

1995-06-07

2000-06-06

Hollinden, Gary E.

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Ultrasound contrast agent

424 95, A61B 813

Patent

active

060714964

ABSTRACT:
The invention relates to ultrasonic contrast agents comprising microparticles which comprise synthetic biodegradable polymer which is a polyalkylcyanoarylate and a gas and/or a fluid with a boiling point below 60.degree. C., processes for the preparation thereof and their use as diagnostic and therapeutic agents.

REFERENCES:
patent: 4142526 (1979-03-01), Zaffaroni et al.
patent: 4265251 (1981-05-01), Tichner
patent: 4370160 (1983-01-01), Ziemelis
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4552812 (1985-11-01), Margel et al.
patent: 4832941 (1989-05-01), Berwing et al.
patent: 4844882 (1989-07-01), Widder
patent: 4913908 (1990-04-01), Couvreur et al.
patent: 5049322 (1991-09-01), Devissaguet et al.
patent: 5107842 (1992-04-01), Levene
patent: 5141738 (1992-08-01), Rasor et al.
patent: 5147631 (1992-09-01), Glajch et al.
patent: 5174930 (1992-12-01), Stainmesse et al.
patent: 5195520 (1993-03-01), Schlief et al.
patent: 5205287 (1993-04-01), Erbel et al.
patent: 5236693 (1993-08-01), Lee
patent: 5342608 (1994-08-01), Moriya et al.
patent: 5393524 (1995-02-01), Quay
patent: 5425366 (1995-06-01), Reinhardt et al.
patent: 5618514 (1997-04-01), Schroeder
patent: 5670135 (1997-09-01), Schroeder
P.L. Edwards et al., "Scattering of focused ultrasound by spherical microparticles", J. Acoust. Soc. AM. 74(3), Sep. 1983, pp. 1006-1011.
Abstract, 88 0188752/27, Jan. 24, 1985.
Abstract, 87 0 18962/03, Jun. 3, 1985
Abstract, 87 08990/13, Aug. 13, 1985.
The United States Pharmacopeia, Twenty-Revision, The National Formulary, Sixteenth Edition, Jan. 1, 1985, pp. 1976-1980.
The United States Pharmacopeia, The National Formula, Official from Jan. 1, 1995, By authority of the U.S. Pharmacopeial Convention, Inc., meeting at Washington, D.C., Mar. 8-10, 1990, p. 1351.
Merck Index Entry 2911, 10th Edition, 1983.
Grounds for the Decision on opposite of EPO Patent 3 98935 based on Application No. 8 9901933.5, Dec. 7, 1998.
Opposition Arguments of Acusphere Against EP 398935, May 5, 1995.
Opposition Arguments of Nycomed Against EP 398935, May 9, 1995.
International Search Report and Examiner's Comments, May 12, 1989.
Deasy, "Microencapsulation and Related Drug Processes," Drugs and the Pharmaceutical Sciences, pp. 219-361 (1984).
"Counter-Response by Opponent II (Acusphere, Inc.) to Proprietor's Response to the Oppositions," Jun. 1996, pp. 1-11.
Declaration of Howard Bernstein, May 5, 1997, pp. 1-12 and Exhibit 1.
Declaration of Edith Mathiowitz, Mar. 24, 1998, 2 pages and Exhibits A, B and C.
Letter by Edith Mathiowitz, Ph.D., may 27, 1998, 2 pages.
Letter by Richard Bassett to EPO re Oral Hearing, May 18, 1998.
Letter by Richard Bassett to EPO re Oral Hearing, May 15, 1997.
Letter by J.C. Marsden to EPO, Jun. 4, 1998.
List of references and publications related to EP 398 935.

Affiliated with

Also associated with

Rating

Polyalkylcyanoacrylate agents and methods for enhancing contrast does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyalkylcyanoacrylate agents and methods for enhancing contrast, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyalkylcyanoacrylate agents and methods for enhancing contrast will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2211137